EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study)

Marie Jaïs, Pascal Roblot, François Maillot, Mohamed Hamidou, Antoine Enfrein, Alain Lescoat, Mathieu Puyade, Mickaël Martin iD, Amandine Perier

Rheumatology International · 30.04.2024 · 44 (11) · 2465-2471

DOI: 10.1007/s00296-024-05589-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Rheumatology International, online erschienen am 30.04.2024. Verfasst von Marie Jaïs und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Poitiers University Hospital, 2 Rue de La Milétrie, 86021, Poitiers Cedex, France. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Prednisone, Antibodies, Monoclonal, Humanized, Immunosuppressive Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicPrednisoneAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsHumansFemaleAdultRetrospective StudiesMiddle AgedGlucocorticoidsTreatment OutcomeDrug Tapering

Stichwörter der Autor:innen

BelimumabCorticosteroidDrug taperingSystemic lupus erythematosus

Substanzen

belimumabPrednisoneAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsGlucocorticoids

Autor:innen und Institutionen

  • Department of Internal Medicine, Poitiers University Hospital, 2 Rue de La Milétrie, 86021, Poitiers Cedex, France.
  • University of Poitiers, Poitiers, France.
  • Department of Internal Medicine and Clinical Immunology, Tours University Hospital, Tours, France.
  • University of Tours, Tours, France.
  • Department of Internal and Vascular Medicine, Nantes University Hospital, Nantes, France.
  • University of Nantes, Nantes, France.

ORCID-Profile: Mickaël Martin

Zitieren

APA

Jaïs, M., Roblot, P., Maillot, F., Hamidou, M., Enfrein, A., Lescoat, A., Puyade, M., Martin, M., & Perier, A. (2024). Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study). Rheumatology International, 44(11), 2465-2471. https://doi.org/10.1007/s00296-024-05589-2

Vancouver

Jaïs M, Roblot P, Maillot F, Hamidou M, Enfrein A, Lescoat A, et al. Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study). Rheumatology International. 2024;44(11):2465-2471. doi:10.1007/s00296-024-05589-2

BibTeX
@article{Jas2024,
  author = {Jaïs, Marie and Roblot, Pascal and Maillot, François and Hamidou, Mohamed and Enfrein, Antoine and Lescoat, Alain and Puyade, Mathieu and Martin, Mickaël and Perier, Amandine},
  title = {Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study)},
  journal = {Rheumatology International},
  year = {2024},
  volume = {44},
  number = {11},
  pages = {2465--2471},
  doi = {10.1007/s00296-024-05589-2}
}
Kostenlos starten →